Alumis (ALMS) Share-based Compensation (2023 - 2026)
Alumis' (ALMS) quarterly Share-based Compensation came in at $152.3 million in Q2 2026, up 717.28% year-over-year from $18.6 million in Q2 2025, and up 130.76% quarter-over-quarter from $66.0 million in Q3 2025.
Alumis (ALMS) Share-based Compensation (2023 - 2026) Analysis & Trends
Alumis (ALMS) has reported Share-based Compensation for 4 consecutive years, with $152.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Share-based Compensation rose 717.28% year-over-year to $152.3 million in Q2 2026; TTM through Jun 2026 was $152.3 million, a 335.65% increase from a year earlier, with the FY2025 full-year figure at $238.1 million, up 337.64% from the prior year.
- Share-based Compensation was $152.3 million for Q2 2026 at Alumis, up from $66.0 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $152.3 million in Q2 2026 and troughed at $1.9 million in Q2 2023.
- A 4-year average of $36.4 million and a median of $13.0 million in 2024 frame the typical range for Share-based Compensation.
- The widest YoY moves for Share-based Compensation: up 2274.86% in 2025, down 57.54% in 2025.
- Over 4 years, Share-based Compensation stood at $2.3 million in 2023, then jumped by 180.09% to $6.4 million in 2024, then surged by 938.06% to $66.0 million in 2025, then soared by 130.76% to $152.3 million in 2026.
- The last three Share-based Compensation figures came in at $152.3 million (Q2 2026), $66.0 million (Q3 2025), and $18.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 221.78 Bn | 207.79 Bn | 7.24 Bn | 247.00 Mn |
| 2 | Gilead Sciences | 189.46 Bn | 186.20 Bn | 6.22 Bn | 231.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.47 Bn | 122.62 Bn | 2.84 Bn | 108.10 Mn |
| 4 | Regeneron Pharmaceuticals | 82.64 Bn | 74.65 Bn | 3.93 Bn | 243.00 Mn |
| 5 | Moderna | 72.84 Bn | 67.70 Bn | 52.00 Mn | 120.00 Mn |
| 6 | Argenx Se | 59.64 Bn | 54.46 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 33.65 Bn | 30.35 Bn | 992.69 Mn | 86.63 Mn |
| 8 | Biogen | 33.30 Bn | 32.01 Bn | 1.96 Bn | 77.40 Mn |
| 9 | Roivant Sciences | 27.62 Bn | 28.31 Bn | 1.16 Mn | 83.34 Mn |
| 10 | Alumis | 1.01 Bn | 506.96 Mn | - | 152.30 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 152.30 Mn |
| Sep 30, 2025 | 66.00 Mn |
| Jun 30, 2025 | 18.64 Mn |
| Mar 31, 2025 | 63.10 Mn |
| Dec 31, 2024 | 6.36 Mn |
| Sep 30, 2024 | 7.31 Mn |
| Jun 30, 2024 | 43.89 Mn |
| Mar 31, 2024 | 2.66 Mn |
| Sep 30, 2023 | 2.27 Mn |
| Jun 30, 2023 | 1.91 Mn |
Alumis Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ALMS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ALMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ALMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();